gaintherapeutics.com - GANX Forvard narx/daromad multiplikatori

Gain Therapeutics, Inc. (GANX) korporativ emblemasi va logotipi

Gain Therapeutics, Inc. (GANX) Gaucher va Parkinson kasalliklari bozorlariga e'tibor qaratgan holda, neyrodegenerativ patologiyalar terapiyasi uchun dori vositalarini ishlab chiqadi. GURU.Markets tizimi tomonidan taqdim etilgan forward P/S koeffitsiyenti sotuvlarning potentsial o'sishini ko'rsatadi, 653.80 esa ushbu metrikaning eng so'nggi qiymatini aks ettiradi. Gain Therapeutics, Inc. (GANX) oqsillarni nishonga olgan holda risklarni diversifikatsiya qiladi va tijorat mahsulotlari mavjud emasligida R&D jarayonlariga AI platformalarini joriy etish xarajatlarni optimallashtiradi.

GANX (gaintherapeutics.com) Narxning kutilayotgan daromadga nisbati tarixi 04.07.2022dan 14.05.2024gacha

GANX (Gain Therapeutics Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning jamlanma tahlili:gaintherapeutics.com GANX
Gain Therapeutics tovar namunasi

Gain Therapeutics, Inc. (GANX) kompaniyasining konservativ tahlili kelajakdagi o'sish uchun to'langan premiumni baholash uchun bozor qiymatini kutilayotgan pul oqimlari bilan solishtirishni talab qiladi. Forward P/S ko'rsatkichi orqali aks etgan bozor kapitalizatsiyasining prognoz qilingan daromadga nisbati platformalar ustidan nazoratni saqlaydigan gibrid sinov autsorsing modelining samaradorligini namoyish etadi, bu esa operatsion xatarlarni minimallashtiradi va kompaniyaning investitsiya profilini barqarorlashtiradi.

Gain Therapeutics, Inc. raqobatchilari

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|National Vision - Narxning prognoz qilingan daromadga nisbati|PGNY - Narxning prognoz qilingan daromadga nisbati|ARDT - Forvard P/S multiplikatori|SEM: Forvard P/S multiplikatori|astranahealth.com (ASTH) - Forvard P/S multiplikatori|MD (mednax.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori usph.com|Forvard P/S multiplikatori PNTG|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Organogenesis Holdings|Forvard P/S multiplikatori NUTX (nutexhealth.com)|Auna SA (AUNA) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SBC: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Jeuveau EOLS|CYH (Community Health Systems Inc) - Forvard narx/daromad multiplikatori|SKIN: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori MDWD|BTMD: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati The Joint Corporation (JYNT)|Forvard P/S multiplikatori DocGo Inc (DCGO)|Sotuvga nisbatan forvard narx P3 Health Partners, Inc.|Forvard P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - Forvard P/S multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|Cuprina Holdings (Cayman) Ltd. (CUPR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Concord Medical|AMS (American Shared Hospital Services Inc) - Forvard P/S multiplikatori|MEDIROM Corp (MRM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALBT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati DIH Holding|Forvard P/S multiplikatori XAGE (carmellcosmetics.com)|NIVF: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATIP: Forvard narx/daromad multiplikatori|CareMax Medical Group - Narxning kutilayotgan daromadga nisbati|Kindly MD (KDLY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODV|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences Corp|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)